ARQT Arcutis Biotherapeutics: Wutah dodolan triwulanan

Logo korporat perusahaan Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics (ARQT) develops unique non-steroidal dermatitis treatments, allowing the brand to maintain flexible pricing power. On GURU.Markets, the quarterly revenue growth rate confirms this strategy, where the value 45.60 captures this metric. Prospects rely on the innovative drug ZORYVE for treating psoriasis and a streamlined distribution system via certified partners, ensuring stable access to pharmacy chains.

Arcutis (ARQT) - Owah-owahan dodolan kuartal marang kuartal saka 04.07.2022 nganti 20.11.2026

Rincian metrik lan analitis perusahaan Arcutis Biotherapeutics Inc (ARQT)

- rega saham lan target rega konsensus:
- data kapitalisasi saham perusahaan:
- indikator dhuwit lan ilining kas:
Analisis umum perusahaan:Arcutis Biotherapeutics (ARQT)
Produk seri Arcutis

The commercialization dynamics of non-steroidal dermatological products from Arcutis Biotherapeutics (ARQT) are directly reflected in the quarterly revenue growth statistics. This indicator calculates the relative rate of change in revenue between reporting periods, allowing investors to assess the pace of business expansion and the fundamental stability of assets by comparing actual operational acceleration with market expectations.